Drug profile · INN
sermorelin acetate
GEREF
sermorelin acetate (GEREF) is a growth hormone-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — sermorelin acetate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
sermorelin acetate (GEREF) is a growth hormone-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Growth hormone-releasing hormone receptor agonist
Primary target: Growth hormone-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is sermorelin acetate?
sermorelin acetate (GEREF) is a growth hormone-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sermorelin acetate?
GEREF is a marketed brand name for sermorelin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sermorelin acetate?
sermorelin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.